Gene · 5169
Papers2,209
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,209
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Primary Indolent Acute Promyelocytic Leukemia. | Hematol Rep | 2026 | 41718414 | PubTator, text mining | PubMed |
| ENPP3 drives ccRCC progression by cGAMP hydrolysis and STING-IFN suppression. | Cancer Biol Ther | 2026 | 41715305 | PubTator, text mining | PubMed |
| Updates in Pediatric Drug Allergy. | Curr Allergy Asthma Rep | 2026 | 41706240 | PubTator, text mining | PubMed |
| Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation. | Curr Allergy Asthma Rep | 2026 | 41701410 | PubTator, text mining | PubMed |
| SIRT7 as a context-dependent biomarker and therapeutic target: Insights from a pan-cancer study. | PLoS One | 2026 | 41642899 | PubTator, text mining | PubMed |
| [Allergens induce activation of blood CCR3+ granulocyte subsets in patients with perennial allergic rhinitis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | 41633695 | PubTator, text mining | PubMed |
| Bispecific and multispecific T-cell engagers: advancing the future of immunotherapy. | Antib Ther | 2026 | 41561192 | PubTator, text mining | PubMed |
| Immunotherapy in clear cell renal cell carcinoma: current Status, novel Strategies, and future perspectives. | Clin Exp Med | 2026 | 41543784 | PubTator, text mining | PubMed |
| Efficacy and safety of mini-cvd combined with venetoclax and azacitidine in philadelphia chromosome-negative acute leukemia of ambiguous lineage: a single-center retrospective study. | Ann Hematol | 2026 | 41540127 | PubTator, text mining | PubMed |
| A succinylation-related prognostic model for predicting lung adenocarcinoma prognosis and guiding immunotherapy. | Clin Proteomics | 2026 | 41484817 | PubTator, text mining | PubMed |
| Neutralizing serum IgE upregulates CD88 and CRTH2 expression on basophils in patients with asthma. | J Allergy Clin Immunol Glob | 2026 | 41394894 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates in urothelial, prostate, and renal cell cancers: A review of current and emerging therapies. | Crit Rev Oncol Hematol | 2026 | 41344557 | PubTator, text mining | PubMed |
| Label-free, machine-learning assisted impedance assessment of basophil activation. | Sens Actuators B Chem | 2026 | 41306684 | PubTator, text mining | PubMed |
| Unlocking Rare Diagnoses: The Essential Role of Molecular Techniques in Hemoglobin Agrinio. A Case Report. | Eur J Haematol | 2026 | 41251196 | PubTator, text mining | PubMed |
| MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia. | Front Allergy | 2025 | 41647192 | PubTator, text mining | PubMed |
| Predictors of early treatment response to antihistamines and omalizumab in chronic spontaneous urticaria. | Front Allergy | 2025 | 41602870 | PubTator, text mining | PubMed |
| Biomarker-Based Precision Prediction of Immunotherapy Response in Hepatocellular Carcinoma. | Diagnostics (Basel) | 2025 | 41515582 | PubTator, text mining | PubMed |
| MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia. | medRxiv | 2025 | 41503473 | PubTator, text mining | PubMed |
| Clinical Characteristics and Diagnosis of Children t(8; 21)/AML1-ETO Positive Acute Myeloid Leukemia with Basophilic Granulocytosis. | Clin Lab | 2025 | 41221736 | PubTator, text mining | PubMed |
| Biomarker-driven mechanisms and therapeutic targets for prostate diseases through mendelian randomization and molecular docking. | Aging Male | 2025 | 41204712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5169/papers?page=2